USA fulfillment
Orders ship from our domestic facility with clear tracking once released.

performance research
Dual-peptide formulation for endocrine and receptor signaling research · 99%+ purity · COA certified · Research use only
Volume discounts
In stock — ships from our USA facility
For research use only · Not for human consumption
Product description
CJC-1295 + Ipamorelin research peptide is supplied as research-use-only lyophilized material with product education, batch documentation, and dosage-specific SKU tracking.
Handling & storage
CJC-1295 + Ipamorelin research peptide is a dual-peptide research formulation supplied for controlled laboratory and analytical investigation of endocrine signaling and peptide-receptor interactions. The formulation combines a growth hormone-releasing hormone (GHRH) analog with Ipamorelin, a synthetic peptide studied for its interaction with the growth hormone secretagogue receptor (GHSR). The combination is of research interest because the two peptides interact with distinct receptor systems. Laboratory models may use the formulation to investigate GHRH receptor-associated signaling alongside GHSR-mediated signaling, providing a framework for studying pathway interactions, receptor pharmacology, endocrine biology, and peptide structure-function relationships under controlled experimental conditions. Research involving CJC-1295 + Ipamorelin may examine receptor activation, downstream cellular signaling, endocrine pathway interactions, peptide pharmacology, and the biological characteristics of combined peptide systems. These areas represent experimental research applications and should not be interpreted as established therapeutic or performance effects. CJC-1295 + Ipamorelin is supplied as a lyophilized research material with batch-specific analytical documentation available for applicable manufacturing lots. Researchers should reference the corresponding Certificate of Analysis for reported identity, CJC-1295 + Ipamorelin purity, composition, and other available analytical specifications. For research use only. Keep lyophilized material protected from light, moisture, and temperature excursions. Follow institutional SOPs, product documentation, and the applicable Certificate of Analysis for storage, handling, preparation, and disposal. Not for human or veterinary consumption. Not intended for diagnostic, therapeutic, performance-enhancing, or clinical use.
Research use only. Not for human or veterinary consumption. Intended for qualified laboratory research.
Product specifications
Product description
CJC-1295 + Ipamorelin research peptide is supplied as research-use-only lyophilized material with product education, batch documentation, and dosage-specific SKU tracking.
Handling & storage
CJC-1295 + Ipamorelin research peptide is a dual-peptide research formulation supplied for controlled laboratory and analytical investigation of endocrine signaling and peptide-receptor interactions. The formulation combines a growth hormone-releasing hormone (GHRH) analog with Ipamorelin, a synthetic peptide studied for its interaction with the growth hormone secretagogue receptor (GHSR). The combination is of research interest because the two peptides interact with distinct receptor systems. Laboratory models may use the formulation to investigate GHRH receptor-associated signaling alongside GHSR-mediated signaling, providing a framework for studying pathway interactions, receptor pharmacology, endocrine biology, and peptide structure-function relationships under controlled experimental conditions. Research involving CJC-1295 + Ipamorelin may examine receptor activation, downstream cellular signaling, endocrine pathway interactions, peptide pharmacology, and the biological characteristics of combined peptide systems. These areas represent experimental research applications and should not be interpreted as established therapeutic or performance effects. CJC-1295 + Ipamorelin is supplied as a lyophilized research material with batch-specific analytical documentation available for applicable manufacturing lots. Researchers should reference the corresponding Certificate of Analysis for reported identity, CJC-1295 + Ipamorelin purity, composition, and other available analytical specifications. For research use only. Keep lyophilized material protected from light, moisture, and temperature excursions. Follow institutional SOPs, product documentation, and the applicable Certificate of Analysis for storage, handling, preparation, and disposal. Not for human or veterinary consumption. Not intended for diagnostic, therapeutic, performance-enhancing, or clinical use.
Research use only. Not for human or veterinary consumption. Intended for qualified laboratory research.
Product specifications
Certificate of analysis
Independently tested. Every batch you receive matches the documentation below.
Purity
99%+
HPLC-verified
HPLC verified batch
Independent verification for this lot. Purity and endotoxin certificates document what is in your vial.
USA-manufactured · COA on every batch · Research use only
Shipping & compliance
Orders ship from our domestic facility with clear tracking once released.
Eligible lots include certificate-of-analysis context near the product decision.
Not for human or veterinary consumption, diagnosis, treatment, or clinical use.
Built for laboratories, institutions, and approved research organizations.
Research overview
For laboratories considering a CJC-1295 + Ipamorelin peptide for sale, reviewing the complete product listing can help confirm the exact formulation, supplied format, research-use designation, and available documentation. This is particularly relevant for procurement teams that need to distinguish a combined peptide formulation from individual peptide products.
Researchers comparing CJC-1295 + Ipamorelin online listings can review the stated product information and applicable documentation before selecting material for their laboratory requirements. Confirming the exact product designation can help maintain consistency between purchasing records and internal laboratory documentation.
Batch documentation
Available per lot
Research overview
Researchers evaluating a CJC-1295 + Ipamorelin supplier can review the applicable Certificate of Analysis, batch information, product specifications, and research-use designation as part of their procurement process.
The applicable CJC-1295 + Ipamorelin COA provides reported analytical information for the relevant manufacturing lot. Researchers reviewing CJC-1295 + Ipamorelin purity can refer to the applicable batch documentation for the reported result.
Those looking to buy CJC-1295 + Ipamorelin peptide can review the product listing, supplied format, available documentation, fulfillment information, and current CJC-1295 + Ipamorelin price before ordering.
Common questions
CJC-1295 + Ipamorelin is a dual-peptide research formulation supplied for controlled laboratory and analytical investigation of endocrine signaling and peptide-receptor interactions.
The formulation combines a GHRH analog with Ipamorelin, a synthetic peptide studied for its interaction with the growth hormone secretagogue receptor (GHSR), as described in the product information.
Applicable manufacturing lots have batch-specific analytical documentation available. Researchers can reference the corresponding CJC-1295 + Ipamorelin COA for reported identity, purity, composition, and other available analytical specifications.
Researchers reviewing CJC-1295 + Ipamorelin purity should refer to the Certificate of Analysis associated with the applicable manufacturing lot for the reported analytical result.
When comparing a CJC-1295 + Ipamorelin supplier, researchers can review the product identity, formulation, supplied format, research-use designation, batch documentation, applicable COA, and stated analytical specifications.
Before you buy CJC-1295 + Ipamorelin peptide, review the exact product formulation, supplied format, research-use designation, applicable documentation, storage information, fulfillment details, and current product listing.
Complete your research
10mg vial
10mg vial
1mg vial